Protocolized Post-Extubation Respiratory Support Study
- Conditions
- Mechanical Ventilation ComplicationAcute Respiratory FailureIntubation Complication
- Interventions
- Other: Usual CareOther: Protocolized post-extubation respiratory support
- Registration Number
- NCT03288311
- Lead Sponsor
- Vanderbilt University Medical Center
- Brief Summary
Invasive mechanical ventilation is common in the medical intensive care unit, and the period of time following extubation remains high risk as 11 to 15% of patients require reintubation after their first extubation. Reintubation is associated with increased rates of nosocomial infection and is an independent predictor of mortality. Non-invasive ventilation and high flow nasal cannula are the only therapies that have been shown to reduce the rate of reintubation. Recent clinical trials suggest that all patients might benefit from some form of post-extubation respiratory support, but use of these therapies in usual care remains low. PROPER is a cluster-randomized, multiple-crossover trial comparing a respiratory therapist driven protocol to provide post-extubation respiratory support to all patients, compared to usual care. The trial will enroll patients undergoing extubation in the Medical ICU at Vanderbilt from October 2017 until March 2019. The primary outcome will be reintubation within 96 hours.
- Detailed Description
PROPER is a prospective, pragmatic, cluster-randomized, multiple-crossover trial comparing a respiratory therapist driven protocol for post-extubation respiratory support to usual care. The primary outcome will be reintubation by 96 hours. All adults (age 18 or older) who receive at least 12 hours of mechanical ventilation and are extubated in the Vanderbilt Medical ICU will be enrolled in the trial. The ICU will be divided into 2 clusters, based on the geographic areas covered by the two respiratory therapist dedicated to that ICU. The study will occur in three month blocks. One cluster will be randomized to receive protocolized post-extubation respiratory support (as prescribed by a protocol and delivered by a respiratory therapist), while the other cluster receives usual care, which can include post-extubation respiratory support when requested by the clinical team. At the end of three months, the clusters will cross-over, such that each cluster will spend half of the study receiving protocolized post-extubation respiratory and half of the study receiving usual care. It is anticipated that approximately 630 patients will be enrolled from the medical ICU during the 18 month study period.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 751
- Patient is located in a participating unit
- Patient undergoing extubation from mechanical ventilation
- Patient has been receiving mechanical ventilation for at least 12 hours
- Age ≥ 18 years old
- Patient is receiving ventilation via a tracheostomy
- Patient is being extubated to comfort measures or has "Do Not Reintubate" order in place at the time of extubation
- Patient has required reintubation after a prior attempt at extubation during this hospitalization
- Unplanned or self-extubation, where immediate reintubation is deemed necessary by the clinical team
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Usual Care Usual Care Qualifying patients undergoing extubation in an ICU bed randomized to usual care will receive standard-of-care treatment, which may include post-extubation respiratory support at the discretion of their clinical team. Protocolized Post-extubation Respiratory Support Protocolized post-extubation respiratory support Qualifying patients undergoing extubation in an ICU bed randomized to post-extubation respiratory support will receive either non-invasive ventilation or high flow nasal cannula (as determined by a prespecified protocol and applied by a respiratory therapist) from the time of extubation until 5AM the following morning
- Primary Outcome Measures
Name Time Method Reintubation within 96 hours of extubation Any placement of an endotracheal tube for any indication within 96 hours of extubation, censored at the first of hospital discharge or 96 hours after extubation
- Secondary Outcome Measures
Name Time Method All-cause In-hospital Death from extubation to discharge or 28 days post-extubation All cause mortality, censored at the first of hospital discharge or 28 days after extubation
Time to Reintubation from extubation to discharge or 28 days post-extubation Time from extubation to reintubation
Number of Patients Requiring Re-intubation for Respiratory Indication within 96 hours of extubation Number of patients in each group with respiratory indication for reintubation.
Use of High Flow Nasal Cannula (HFNC) or Non-invasive Ventilation (NIV) Beyond 24 Hours Post-extubation from 24 hours post extubation to 96 hours post-extubation Use of non-invasive ventilation or high flow nasal cannula beyond 24 hours post-extubation
ICU-free Days from extubation to discharge or 28 days post-extubation number of days alive from final ICU transfer until study day 28
Number of Patients Requiring Reintubation for Laryngeal Edema within 96 hours of extubation Percentage of patients in each group with laryngeal edema as the indication for reintubation
Lowest S/F Ratio between 0-6 hours, 6-12 hours, and 12-24 hours after extubation Lowest ratio of O2 saturation to concentration inhaled oxygen (FIO2)
Ventilator-free Days from extubation to discharge or 28 days post-extubation number of days alive from final invasive mechanical ventilation until study day 28
Number of Patients With Delirium within 96 hours of extubation As defined by Confusion Assessment Method for the ICU (CAM-ICU) score and reported by bedside nurse. A report of "Yes" indicates the presence of delirium, which is reflected in the reported cases.
Number of Patients With Agitation within 96 hours of extubation As defined by RAS score and reported by bedside nurse
Highest Respiratory Rate between 0-6 hours, 6-12 hours, and 12-24 hours after extubation Highest respiratory rate
Trial Locations
- Locations (1)
Vanderbilt University Medical Center
🇺🇸Nashville, Tennessee, United States